Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 1
2010 1
2014 1
2015 1
2017 1
2018 3
2019 2
2020 1
2021 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko IV, Kalinovsky DV, Doronin II, Deyev SM, Kholodenko RV. Kholodenko IV, et al. Among authors: kholodenko rv. J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. J Immunol Res. 2018. PMID: 30116755 Free PMC article. Review.
Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
Kholodenko IV, Kurbatov LK, Kholodenko RV, Manukyan GV, Yarygin KN. Kholodenko IV, et al. Among authors: kholodenko rv. Cells. 2019 Sep 22;8(10):1127. doi: 10.3390/cells8101127. Cells. 2019. PMID: 31546729 Free PMC article. Review.
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Kalinovsky DV, Kibardin AV, Kholodenko IV, Svirshchevskaya EV, Doronin II, Konovalova MV, Grechikhina MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: kholodenko rv. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646. J Immunother Cancer. 2022. PMID: 35764367 Free PMC article.
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype.
Sorokin M, Kholodenko I, Kalinovsky D, Shamanskaya T, Doronin I, Konovalov D, Mironov A, Kuzmin D, Nikitin D, Deyev S, Buzdin A, Kholodenko R. Sorokin M, et al. Among authors: kholodenko r. Biomedicines. 2020 May 30;8(6):142. doi: 10.3390/biomedicines8060142. Biomedicines. 2020. PMID: 32486168 Free PMC article.
Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death.
Kholodenko IV, Gisina AM, Manukyan GV, Majouga AG, Svirshchevskaya EV, Kholodenko RV, Yarygin KN. Kholodenko IV, et al. Among authors: kholodenko rv. Curr Issues Mol Biol. 2022 Jul 30;44(8):3428-3443. doi: 10.3390/cimb44080236. Curr Issues Mol Biol. 2022. PMID: 36005132 Free PMC article.
TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype.
Kim YS, Potashnikova DM, Gisina AM, Kholodenko IV, Kopylov AT, Tikhonova OV, Kurbatov LK, Saidova AA, Tvorogova AV, Kholodenko RV, Belousov PV, Vorobjev IA, Zgoda VG, Yarygin KN, Lupatov AY. Kim YS, et al. Among authors: kholodenko rv. Int J Mol Sci. 2022 Aug 30;23(17):9874. doi: 10.3390/ijms23179874. Int J Mol Sci. 2022. PMID: 36077272 Free PMC article.
20 results